Insider · CIK 0001220630

ACKERMAN JOEL

Reports to the SEC for 4 companies · HACKENSACK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001220630

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion	Director	MExercise/Conversion	+69.8K sh	$1.60	+$112K	1,126,333
2026-10-15	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−69.8K sh	$1.60	−$112K	0
2026-05-07	DVADAVITA INC.S Sale	CFO and Treasurer	SSale	−51.5K sh	$192.10	−$9.89M	132,434
2026-03-15	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+5,706 sh	—	—	226,725
2026-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−3,362 sh	$150.72	−$507K	223,363
2026-03-15	DVADAVITA INC. · Stock Appreciation RightsA Award	CFO and Treasurer	AAward	+15.4K sh	—	—	15,427
2026-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−33.7K sh	$150.72	−$5.08M	189,670
2026-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−5,765 sh	$150.72	−$869K	183,905
2026-03-10	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+66K sh	—	—	221,019
2026-03-10	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+6,585 sh	—	—	155,022
2026-02-06	DVADAVITA INC. · Stock Appreciation RightsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−44.1K sh	—	—	0
2026-02-06	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−5,100 sh	$149.22	−$761K	148,437
2026-02-06	DVADAVITA INC.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+44.1K sh	$108.93	+$4.8M	185,705
2026-02-06	DVADAVITA INC.D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−32.2K sh	$149.22	−$4.8M	153,537
2025-11-05	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award	Director	AAward	+21.2K sh	$6.80	+$144K	21,216
2025-10-30	CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion	Director	MExercise/Conversion	+94.4K sh	$2.10	+$198K	1,056,539
2025-10-30	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−94.4K sh	$2.10	−$198K	0
2025-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−3,331 sh	$143.45	−$478K	141,640
2025-03-15	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+5,995 sh	—	—	148,064
2025-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−3,093 sh	$143.45	−$444K	144,971
2025-03-15	DVADAVITA INC. · Stock Appreciation RightsA Award	CFO and Treasurer	AAward	+16.6K sh	—	—	16,597
2025-03-12	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+7,394 sh	—	—	134,848
2025-03-12	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+7,221 sh	—	—	142,069
2024-11-12	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award	Director	AAward	+43.2K sh	$4.64	+$200K	43,190
2024-10-31	CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion	Director	MExercise/Conversion	+88.5K sh	$2.10	+$186K	945,467
2024-10-31	CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$5.43	+$90.5K	962,134
2024-10-31	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−88.5K sh	$2.10	−$186K	0
2024-10-31	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	$5.43	−$90.5K	0
2024-09-16	DVADAVITA INC. · Stock Appreciation RightsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−79K sh	—	—	0
2024-09-16	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−21.6K sh	$163.56	−$3.53M	127,454
2024-09-16	DVADAVITA INC.D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−36.7K sh	$163.56	−$6M	149,056
2024-09-16	DVADAVITA INC.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+79K sh	$75.95	+$6M	185,740
2024-08-28	DVADAVITA INC.S Sale	CFO and Treasurer	SSale	−4,740 sh	$155.02	−$735K	106,741
2024-08-27	DVADAVITA INC.S Sale	CFO and Treasurer	SSale	−64K sh	$155.06	−$9.93M	111,481
2024-03-15	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+11K sh	—	—	183,574
2024-03-15	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−8,064 sh	$136.00	−$1.1M	175,510
2024-03-14	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+14.3K sh	—	—	171,152
2024-03-14	DVADAVITA INC.A Award	CFO and Treasurer	AAward	+1,445 sh	—	—	172,597
2024-03-06	DVADAVITA INC. · Stock Appreciation RightsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−55K sh	—	—	0
2024-03-06	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−17.1K sh	$134.65	−$2.31M	156,803
2024-03-06	DVADAVITA INC.D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−21.4K sh	$134.65	−$2.88M	173,952
2024-03-06	DVADAVITA INC.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+55K sh	$52.41	+$2.88M	195,360
2024-02-21	DVADAVITA INC. · Stock Appreciation RightsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−55K sh	—	—	55,000
2024-02-21	DVADAVITA INC.F Tax Payment	CFO and Treasurer	FTax Payment	−14.9K sh	$123.00	−$1.84M	140,360
2024-02-21	DVADAVITA INC.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+55K sh	$52.41	+$2.88M	178,726
2024-02-21	DVADAVITA INC.D Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−23.4K sh	$123.00	−$2.88M	155,290
2023-11-03	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award	Director	AAward	+35.8K sh	$5.51	+$197K	35,750
2023-10-17	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−14.6K sh	$2.10	−$30.6K	0
2023-10-17	CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−100K sh	$2.10	−$210K	0
2023-10-17	CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion	Director	MExercise/Conversion	+115K sh	$2.10	+$241K	856,997

Recent filings

Accepted (ET)
Oct 16 12:454
ACKERMAN JOEL0001628280-26-066091
SEC(opens sec.gov)
May 114
ACKERMAN JOEL0000927066-26-000065
SEC(opens sec.gov)
Mar 174
ACKERMAN JOEL0000927066-26-000038
SEC(opens sec.gov)
Mar 124
ACKERMAN JOEL0000927066-26-000017
SEC(opens sec.gov)
Feb 94
ACKERMAN JOEL0000927066-26-000008
SEC(opens sec.gov)
Nov 74
ACKERMAN JOEL0001628280-25-050467
SEC(opens sec.gov)
Nov 64
ACKERMAN JOEL0001628280-25-049954
SEC(opens sec.gov)
Mar 184
ACKERMAN JOEL0000927066-25-000056
SEC(opens sec.gov)

Companies

Address

C/O CHAMPIONS ONCOLOGY, INC. ONE UNIVERSITY PLACE, SUITE 307

HACKENSACK, NJ, 07601